EUVIMEDEUVIMED entdecken
Open Access

Overcoming barriers in HPV vaccination and screening programs

Alex Vorsters, Marc Arbyn, Marc Baay, Xavier Bosch, Silvia de Sanjosé, Sharon Hanley, Emilie Karafillakis, Pier Luigi Lopalco, Kevin G Pollock, Joanne Yarwood, Pierre Van Damme

Papillomavirus Research · 2017-12 · 4 · 45-53

DOI: 10.1016/j.pvr.2017.07.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Papillomavirus Research, 2017-12. Verfasst von Alex Vorsters und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium. Electronic address: alex.vo…. Hauptthemen laut MEDLINE: Early Detection of Cancer. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: GSK, Merck, SPMSD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerCommunicationFemaleHealth PersonnelHumansImmunization ProgramsMass ScreeningPapillomaviridaePapillomavirus InfectionsPapillomavirus VaccinesVaccination

Stichwörter der Autor:innen

(max 6) Human papillomavirusBarriersScreeningVaccineVaccine confidence

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Centre for Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium. Electronic address: alex.vorsters@uantwerpen.be.
  • Unit of Cancer Epidemiology, Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium.
  • P95, Epidemiology and Pharmacovigilance Consulting and Services, Leuven, Belgium.
  • Cancer Research Epidemiology Program, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.
  • Cancer Research Epidemiology Program, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain; CIBER Epidemiologia y Salud Pública, Barcelona, Spain.
  • Department of Women's Health Medicine, Hokkaido University Graduate School of Medicine, Kita Ku, Sapporo, Japan.

Förderung

  • GSK
  • Merck
  • SPMSD
  • University of Antwerp
  • Qiagen
  • Roche
  • AGAUR

Zitieren

APA

Vorsters, A., Arbyn, M., Baay, M., Bosch, X., de Sanjosé, S., Hanley, S., Karafillakis, E., Lopalco, P. L., Pollock, K. G., Yarwood, J., & Van Damme, P. (2017). Overcoming barriers in HPV vaccination and screening programs. Papillomavirus Research, 4, 45-53. https://doi.org/10.1016/j.pvr.2017.07.001

Vancouver

Vorsters A, Arbyn M, Baay M, Bosch X, de Sanjosé S, Hanley S, et al. Overcoming barriers in HPV vaccination and screening programs. Papillomavirus Research. 2017;4:45-53. doi:10.1016/j.pvr.2017.07.001

BibTeX
@article{Vorsters2017,
  author = {Vorsters, Alex and Arbyn, Marc and Baay, Marc and Bosch, Xavier and de Sanjosé, Silvia and Hanley, Sharon and Karafillakis, Emilie and Lopalco, Pier Luigi and Pollock, Kevin G and Yarwood, Joanne and Van Damme, Pierre},
  title = {Overcoming barriers in HPV vaccination and screening programs},
  journal = {Papillomavirus Research},
  year = {2017},
  volume = {4},
  pages = {45--53},
  doi = {10.1016/j.pvr.2017.07.001}
}
Kostenlos starten →